Determination of the 1L-5-6L MGF110 Genes Influence on the Biological Properties of the African Swine Fever Virus (Asfarviridae; Asfivirus) “Volgograd/14c” in vivo
Author:
Vlasov Mikhail E.1ORCID, Nefedeva Mariia V.1ORCID, Kudryashov Dmitriy A.1ORCID, Titov Ilya A.1ORCID
Affiliation:
1. 1 Federal Research Center for Virology and Microbiology , Volginsky , Russia .
Abstract
Abstract
African swine fever continues to pose a global agricultural problem due to the absence of vaccine prevention and the high cost of anti-epizootic measures. This study examines the functional role of the African swine fever virus (ASFV) 1L-5-6L multigene family 110 genes in vivo. Four clinically healthy Large White pigs were used in this study. Two groups of animals were inoculated with either the parental strain or the deletion variant, respectively. For subsequent challenge infection, the homologous virulent strain “Stavropol 01/08” was used. Blood samples were collected at specific time intervals. The ASFV infectious activity was determined by titration in porcine blood-derived macrophages. Virus-specific antibodies to the ASFV p30 protein were detected using an enzyme-linked immunosorbent assay (ELISA).
The results of real-time polymerase chain reaction (PCR) showed a significant difference in Ct values between samples from the two groups of animals. The determination of ASFV infectious activity in blood samples demonstrated the presence of the virus in animals immunized with the parental strain. The virus was not detected in samples from animals immunized with the deletion strain. The ELISA method demonstrated the presence of p30 protein antibodies in serum samples from 10 to 14 days after immunization with the parental strain, while no antibodies were detected in serum samples from animals immunized with the deletion strain.
The properties of the ASFV recombinant strain “Volgograd/D(1L-5-6L) MGF110” were studied in an in vivo experiment. It was found that the deletion strain does not reproduce in animals, unlike the parental strain.
Publisher
Walter de Gruyter GmbH
Reference20 articles.
1. Li Z, Chen W, Qiu Z, Li Y, Fan J, Wu K, Li X, Zhao M, Ding H, Fan S, Chen J: African Swine Fever Virus: A Review. Life (Basel, Switzerland) 2022, 12(8):1255. 2. Chen W, Zhao D, He X, Liu R, Wang Z, Zhang X, Li F, Shan D, Chen H, Zhang J, Wang L, Wen Z, Wang X, Guan Y, Liu J, Bu Z: A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Science China. Life Sci 2020, 63(5):623–634. 3. Urbano AC, Ferreira F: African swine fever control and prevention: an update on vaccine development. Emerg Microbes Infect 2022, 11(1):2021–2033. 4. Rathakrishnan A, Connell S, Petrovan V, Moffat K, Goatley LC, Jabbar T, Sánchez-Cordón PJ, Reis AL, Dixon LK: Differential Effect of Deleting Members of African Swine Fever Virus Multigene Families 360 and 505 from the Genotype II Georgia 2007/1 Isolate on Virus Replication, Virulence, and Induction of Protection. J Virol 2022, 96(6):e0189921. 5. Ding M, Dang W, Liu H, Xu F, Huang H, Sunkang Y, Li T, Pei J, Liu X, Zhang Y, Zheng H: Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge. J Virol 2022, 96(14):e0032922.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|